Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dicycloplatin (TP21) for TACE in Unresectable Hepatocellular Carcinoma
NCT05472896Phase 3Unknown
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 3 trial of dicycloplatin in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
dicycloplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05472896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05472896.